|
1
|
Lai EC: Micro RNAs are complementary to 3′
UTR sequence motifs that mediate negative post-transcriptional
regulation. Nat Genet. 30:363–364. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Selbach M, Schwanhäusser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Isomoto H, Matsushima K, Inoue N, Hayashi
T, Nakayama T, Kunizaki M, Hidaka S, Nakayama M, Hisatsune J,
Nakashima M, et al: Interweaving microRNAs and proinflammatory
cytokines in gastric mucosa with reference to H. pylori infection.
J Clin Immunol. 32:290–299. 2012. View Article : Google Scholar
|
|
4
|
Schoof CR, Botelho EL, Izzotti A and
Vasques Ldos R: MicroRNAs in cancer treatment and prognosis. Am J
Cancer Res. 2:414–433. 2012.PubMed/NCBI
|
|
5
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tili E, Michaille JJ and Croce CM:
MicroRNAs play a central role in molecular dysfunctions linking
inflammation with cancer. Immunol Rev. 253:167–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Denison MS, Soshilov AA, He G, DeGroot DE
and Zhao B: Exactly the same but different: promiscuity and
diversity in the molecular mechanisms of action of the aryl
hydrocarbon (dioxin) receptor. Toxicol Sci. 124:1–22. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McIntosh BE, Hogenesch JB and Bradfield
CA: Mammalian Per-Arnt-Sim proteins in environmental adaptation.
Annu Rev Physiol. 72:625–645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng S, Cao Z and Wang X: Role of aryl
hydrocarbon receptor in cancer. Biochim Biophys Acta. 1836:197–210.
2013.PubMed/NCBI
|
|
10
|
Shen G, Li X, Jia YF, Piazza GA and Xi Y:
Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin.
34:336–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hay MP, Hicks KO and Wang J:
Hypoxia-directed drug strategies to target the tumor
microenvironment. Adv Exp Med Biol. 772:111–145. 2014. View Article : Google Scholar
|
|
12
|
Safe S, Lee SO and Jin UH: Role of the
aryl hydrocarbon receptor in carcinogenesis and potential as a drug
target. Toxicol Sci. 135:1–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agrawal R, Pandey P, Jha P, Dwivedi V,
Sarkar C and Kulshreshtha R: Hypoxic signature of microRNAs in
glioblastoma: Insights from small RNA deep sequencing. BMC
Genomics. 15:6862014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grosso S, Doyen J, Parks SK, Bertero T,
Paye A, Cardinaud B, Gounon P, Lacas-Gervais S, Noël A, Pouysségur
J, et al: MiR-210 promotes a hypoxic phenotype and increases
radioresistance in human lung cancer cell lines. Cell Death Dis.
4:e5442013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakada C, Tsukamoto Y, Matsuura K, Nguyen
TL, Hijiya N, Uchida T, Sato F, Mimata H, Seto M and Moriyama M:
Overexpression of miR-210, a downstream target of HIF1α, causes
centrosome amplification in renal carcinoma cells. J Pathol.
224:280–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Z, Li Y, Zhang H, Huang P and Luthra
R: Hypoxia-regulated microRNA-210 modulates mitochondrial function
and decreases ISCU and COX10 expression. Oncogene. 29:4362–4368.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Camps C, Saini HK, Mole DR, Choudhry H,
Reczko M, Guerra-Assunção JA, Tian YM, Buffa FM, Harris AL,
Hatzigeorgiou AG, et al: Integrated analysis of microRNA and mRNA
expression and association with HIF binding reveals the complexity
of microRNA expression regulation under hypoxia. Mol Cancer.
13:282014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bruning U, Cerone L, Neufeld Z,
Fitzpatrick SF, Cheong A, Scholz CC, Simpson DA, Leonard MO,
Tambuwala MM, Cummins EP, et al: MicroRNA-155 promotes resolution
of hypoxia-inducible factor 1alpha activity during prolonged
hypoxia. Mol Cell Biol. 31:4087–4096. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q,
Jiang BH and Liu LZ: Chronic arsenic exposure and angiogenesis in
human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/
COX-2 pathway. Environ Health Perspect. 122:255–261.
2014.PubMed/NCBI
|
|
20
|
Lei Z, Li B, Yang Z, Fang H, Zhang GM,
Feng ZH and Huang B: Regulation of HIF-1alpha and VEGF by miR-20b
tunes tumor cells to adapt to the alteration of oxygen
concentration. PLoS One. 4:e76292009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rane S, He M, Sayed D, Vashistha H,
Malhotra A, Sadoshima J, Vatner DE, Vatner SF and Abdellatif M:
Downregulation of miR-199a derepresses hypoxia-inducible
factor-1alpha and Sirtuin 1 and recapitulates hypoxia
preconditioning in cardiac myocytes. Circ Res. 104:879–886. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gits CM, van Kuijk PF, de Rijck JC,
Muskens N, Jonkers MB, van IJcken WF, Mathijssen RH, Verweij J,
Sleijfer S and Wiemer EA: MicroRNA response to hypoxic stress in
soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.
BMC Cancer. 14:4292014. View Article : Google Scholar
|
|
23
|
Ghosh G, Subramanian IV, Adhikari N, Zhang
X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, et
al: Hypoxia-induced microRNA-424 expression in human endothelial
cells regulates HIF-α isoforms and promotes angiogenesis. J Clin
Invest. 120:4141–4154. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gordon MW, Yan F, Zhong X, Mazumder PB,
Xu-Monette ZY, Zou D, Young KH, Ramos KS and Li Y: Regulation of
p53-targeting microRNAs by polycyclic aromatic hydrocarbons:
Implications in the etiology of multiple myeloma. Mol Carcinog. May
6–2014.(Epub ahead of print). View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang X, Ding L, Bennewith KL, Tong RT,
Welford SM, Ang KK, Story M, Le QT and Giaccia AJ:
Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Mol Cell. 35:856–867. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Bian S and Yang CS: Green tea
polyphenol EGCG suppresses lung cancer cell growth through
upregulating miR-210 expression caused by stabilizing HIF-1α.
Carcinogenesis. 32:1881–1889. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li L, Huang K, You Y, Fu X, Hu L, Song L
and Meng Y: Hypoxia-induced miR-210 in epithelial ovarian cancer
enhances cancer cell viability via promoting proliferation and
inhibiting apoptosis. Int J Oncol. 44:2111–2120. 2014.PubMed/NCBI
|
|
28
|
Hwang HW, Baxter LL, Loftus SK, Cronin JC,
Trivedi NS, Borate B and Pavan WJ: Distinct microRNA expression
signatures are associated with melanoma subtypes and are regulated
by HIF1A. Pigment Cell Melanoma Res. 27:777–787. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mace TA, Collins AL, Wojcik SE, Croce CM,
Lesinski GB and Bloomston M: Hypoxia induces the overexpression of
microRNA-21 in pancreatic cancer cells. J Surg Res. 184:855–860.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding G, Huang G, Liu HD, Liang HX, Ni YF,
Ding ZH, Ni GY and Hua HW: MiR-199a suppresses the hypoxia-induced
proliferation of non-small cell lung cancer cells through targeting
HIF1α. Mol Cell Biochem. 384:173–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM,
Zhang JP, Jiang BH and Feng ZQ: Lentivirus-mediated overexpression
of microRNA-199a inhibits cell proliferation of human
hepatocellular carcinoma. Cell Biochem Biophys. 62:237–244. 2012.
View Article : Google Scholar
|
|
32
|
Shang W, Chen X, Nie L, Xu M, Chen N, Zeng
H and Zhou Q: miR199b suppresses expression of hypoxia-inducible
factor 1α (HIF-1α) in prostate cancer cells. Int J Mol Sci.
14:8422–8436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang L, Sun ZJ, Bian Y and Kulkarni AB:
MicroRNA-135b acts as a tumor promoter by targeting the
hypoxia-inducible factor pathway in genetically defined mouse model
of head and neck squamous cell carcinoma. Cancer Lett. 331:230–238.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Taguchi A, Yanagisawa K, Tanaka M, Cao K,
Matsuyama Y, Goto H and Takahashi T: Identification of
hypoxia-inducible factor-1 alpha as a novel target for miR-17–92
microRNA cluster. Cancer Res. 68:5540–5545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Trivellin G, Butz H, Delhove J, Igreja S,
Chahal HS, Zivkovic V, McKay T, Patócs A, Grossman AB and Korbonits
M: MicroRNA miR-107 is overexpressed in pituitary adenomas and
inhibits the expression of aryl hydrocarbon receptor-interacting
protein in vitro. Am J Physiol Endocrinol Metab. 303:E708–E719.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Duan H, Jiang Y, Zhang H and Wu Y: MiR-320
and miR-494 affect cell cycles of primary murine bronchial
epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro.
24:928–935. 2010. View Article : Google Scholar
|
|
37
|
Yuan Q, Loya K, Rani B, Möbus S,
Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M, et
al: MicroRNA-221 overexpression accelerates hepatocyte
proliferation during liver regeneration. Hepatology. 57:299–310.
2013. View Article : Google Scholar
|
|
38
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Forsythe JA, Jiang BH, Iyer NV, Agani F,
Leung SW, Koos RD and Semenza GL: Activation of vascular
endothelial growth factor gene transcription by hypoxia-inducible
factor 1. Mol Cell Biol. 16:4604–4613. 1996.PubMed/NCBI
|
|
40
|
Roman AC, Carvajal-Gonzalez JM, Rico-Leo
EM and Fernandez-Salguero PM: Dioxin receptor deficiency impairs
angiogenesis by a mechanism involving VEGF-A depletion in the
endothelium and transforming growth factor-beta overexpression in
the stroma. J Biol Chem. 284:25135–25148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ceradini DJ, Kulkarni AR, Callaghan MJ,
Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP
and Gurtner GC: Progenitor cell trafficking is regulated by hypoxic
gradients through HIF-1 induction of SDF-1. Nat Med. 10:858–864.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu YY, Chen YL, Jao YC, Hsieh IS, Chang KC
and Hong TM: miR-320 regulates tumor angiogenesis driven by
vascular endothelial cells in oral cancer by silencing neuropilin
1. Angiogenesis. 17:247–260. 2014. View Article : Google Scholar
|
|
43
|
Ramakrishnan S, Anand V and Roy S:
Vascular endothelial growth factor signaling in hypoxia and
inflammation. J Neuroimmune Pharmacol. 9:142–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu LZ, Li C, Chen Q, Jing Y, Carpenter R,
Jiang Y, Kung HF, Lai L and Jiang BH: MiR-21 induced angiogenesis
through AKT and ERK activation and HIF-1α expression. PLoS One.
6:e191392011. View Article : Google Scholar
|
|
45
|
Cascio S, D’Andrea A, Ferla R, Surmacz E,
Gulotta E, Amodeo V, Bazan V, Gebbia N and Russo A: miR-20b
modulates VEGF expression by targeting HIF-1 alpha and STAT3 in
MCF-7 breast cancer cells. J Cell Physiol. 224:242–249.
2010.PubMed/NCBI
|
|
46
|
He J, Jing Y, Li W, Qian X, Xu Q, Li FS,
Liu LZ, Jiang BH and Jiang Y: Roles and mechanism of miR-199a and
miR-125b in tumor angiogenesis. PLoS One. 8:e566472013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yamakuchi M, Yagi S, Ito T and Lowenstein
CJ: MicroRNA-22 regulates hypoxia signaling in colon cancer cells.
PLoS One. 6:e202912011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhou B, Ma R, Si W, Li S, Xu Y, Tu X and
Wang Q: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor
angiogenesis and growth. Cancer Lett. 333:159–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shi ZM, Wang J, Yan Z, You YP, Li CY, Qian
X, Yin Y, Zhao P, Wang YY, Wang XF, et al: MiR-128 inhibits tumor
growth and angiogenesis by targeting p70S6K1. PLoS One.
7:e327092012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li
D, Lai L and Jiang BH: MiR-145 directly targets p70S6K1 in cancer
cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res.
40:761–774. 2012. View Article : Google Scholar :
|
|
51
|
Cha ST, Chen PS, Johansson G, Chu CY, Wang
MY, Jeng YM, Yu SL, Chen JS, Chang KJ, Jee SH, et al: MicroRNA-519c
suppresses hypoxia-inducible factor-1alpha expression and tumor
angiogenesis. Cancer Res. 70:2675–2685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xue G, Yan HL, Zhang Y, Hao LQ, Zhu XT,
Mei Q and Sun SH: c-Myc-mediated repression of miR-15–16 in hypoxia
is induced by increased HIF-2alpha and promotes tumor angiogenesis
and metastasis by upregulating FGF2. Oncogene. 34:1393–1406. 2015.
View Article : Google Scholar
|
|
53
|
Zhang S, Kim K, Jin UH, Pfent C, Cao H,
Amendt B, Liu X, Wilson-Robles H and Safe S: Aryl hydrocarbon
receptor agonists induce microRNA-335 expression and inhibit lung
metastasis of estrogen receptor negative breast cancer cells. Mol
Cancer Ther. 11:108–118. 2012. View Article : Google Scholar :
|
|
54
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1alpha. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Joshi HP, Subramanian IV, Schnettler EK,
Ghosh G, Rupaimoole R, Evans C, Saluja M, Jing Y, Cristina I, Roy
S, et al: Dynamin 2 along with microRNA-199a reciprocally regulate
hypoxia-inducible factors and ovarian cancer metastasis. Proc Natl
Acad Sci USA. 111:5331–5336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang H, Pu J, Qi T, Qi M, Yang C, Li S,
Huang K, Zheng L and Tong Q: MicroRNA-145 inhibits the growth,
invasion, metastasis and angiogenesis of neuroblastoma cells
through targeting hypoxia-inducible factor 2 alpha. Oncogene.
33:387–397. 2014. View Article : Google Scholar
|
|
57
|
Chen L, Han L, Zhang K, Shi Z, Zhang J,
Zhang A, Wang Y, Song Y, Li Y, Jiang T, et al: VHL regulates the
effects of miR-23b on glioma survival and invasion via suppression
of HIF-1α/VEGF and β-catenin/Tcf-4 signaling. Neuro-oncol.
14:1026–1036. 2012. View Article : Google Scholar
|
|
58
|
Cao P, Deng Z, Wan M, Huang W, Cramer SD,
Xu J, Lei M and Sui G: MicroRNA-101 negatively regulates Ezh2 and
its expression is modulated by androgen receptor and HIF-1alpha/
HIF-1beta. Mol Cancer. 9:1082010. View Article : Google Scholar
|
|
59
|
Chio CC, Lin JW, Cheng HA, Chiu WT, Wang
YH, Wang JJ, Hsing CH and Chen RM: MicroRNA-210 targets
antiapoptotic Bcl-2 expression and mediates hypoxia-induced
apoptosis of neuroblastoma cells. Arch Toxicol. 87:459–468. 2013.
View Article : Google Scholar
|
|
60
|
Yang W, Sun T, Cao J, Liu F, Tian Y and
Zhu W: Downregulation of miR-210 expression inhibits proliferation,
induces apoptosis and enhances radiosensitivity in hypoxic human
hepatoma cells in vitro. Exp Cell Res. 318:944–954. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hecht E, Zago M, Sarill M, Rico de Souza
A, Gomez A, Matthews J, Hamid Q, Eidelman DH and Baglole CJ: Aryl
hydrocarbon receptor-dependent regulation of miR-196a expression
controls lung fibroblast apoptosis but not proliferation. Toxicol
Appl Pharmacol. 280:511–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Aisenberg AC and Potter VR: Studies on the
Pasteur effect. II Specific mechanisms. J Biol Chem. 224:1115–1127.
1957.PubMed/NCBI
|
|
63
|
Chan SY, Zhang YY, Hemann C, Mahoney CE,
Zweier JL and Loscalzo J: MicroRNA-210 controls mitochondrial
metabolism during hypoxia by repressing the iron-sulfur cluster
assembly proteins ISCU1/2. Cell Metab. 10:273–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
McCormick RI, Blick C, Ragoussis J,
Schoedel J, Mole DR, Young AC, Selby PJ, Banks RE and Harris AL:
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal
cancer, regulates ISCU and correlates with good prognosis. Br J
Cancer. 108:1133–1142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Favaro E, Ramachandran A, McCormick R, Gee
H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, et al:
MicroRNA-210 regulates mitochondrial free radical response to
hypoxia and krebs cycle in cancer cells by targeting iron sulfur
cluster protein ISCU. PLoS One. 5:e103452010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
He M, Lu Y, Xu S, Mao L, Zhang L, Duan W,
Liu C, Pi H, Zhang Y, Zhong M, et al: MiRNA-210 modulates a
nickel-induced cellular energy metabolism shift by repressing the
iron-sulfur cluster assembly proteins ISCU1/2 in Neuro-2a cells.
Cell Death Dis. 5:e10902014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Puisségur MP, Mazure NM, Bertero T,
Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K,
Cardinaud B, Hofman V, et al: miR-210 is overexpressed in late
stages of lung cancer and mediates mitochondrial alterations
associated with modulation of HIF-1 activity. Cell Death Differ.
18:465–478. 2011. View Article : Google Scholar :
|
|
68
|
Fasanaro P, Greco S, Lorenzi M, Pescatori
M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M,
et al: An integrated approach for experimental target
identification of hypoxia-induced miR-210. J Biol Chem.
284:35134–35143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Tanaka H, Sasayama T, Tanaka K, Nakamizo
S, Nishihara M, Mizukawa K, Kohta M, Koyama J, Miyake S, Taniguchi
M, et al: MicroRNA-183 upregulates HIF-1α by targeting isocitrate
dehydrogenase 2 (IDH2) in glioma cells. J Neurooncol. 111:273–283.
2013. View Article : Google Scholar
|
|
70
|
Li W, Wang J, Chen QD, Qian X, Li Q, Yin
Y, Shi ZM, Wang L, Lin J, Liu LZ, et al: Insulin promotes glucose
consumption via regulation of miR-99a/mTOR/PKM2 pathway. PLoS One.
8:e649242013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li D, Liu C, Yu H, et al: AhR is
negatively regulated by miR-203 in response to TCDD or BaP
treatment. Toxicol Res (Camb). 2:142–151. 2013.
|
|
72
|
Nguyen NT, Nakahama T, Le DH, Van Son L,
Chu HH and Kishimoto T: Aryl hydrocarbon receptor and kynurenine:
Recent advances in autoimmune disease research. Front Immunol.
5:5512014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang H, Flach H, Onizawa M, Wei L, McManus
MT and Weiss A: Negative regulation of Hif1a expression and TH17
differentiation by the hypoxia-regulated microRNA miR-210. Nat
Immunol. 15:393–401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Xu Z, Zhao L, Zhu LY, He M, Zheng L and Wu
Y: MicroRNA-17, 20a regulates the proangiogenic function of
tumor-associated macrophages via targeting hypoxia-inducible factor
2α. PLoS One. 8:e778902013. View Article : Google Scholar
|
|
75
|
Poitz DM, Augstein A, Gradehand C, Ende G,
Schmeisser A and Strasser RH: Regulation of the Hif-system by
micro-RNA 17 and 20a - role during monocyte-to-macrophage
differentiation. Mol Immunol. 56:442–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Csak T, Bala S, Lippai D, Satishchandran
A, Catalano D, Kodys K and Szabo G: microRNA-122 regulates
hypoxia-inducible factor-1 and vimentin in hepatocytes and
correlates with fibrosis in diet-induced steatohepatitis. Liver
Int. 35:532–541. 2015. View Article : Google Scholar
|
|
77
|
Bleck B, Grunig G, Chiu A, Liu M, Gordon
T, Kazeros A and Reibman J: MicroRNA-375 regulation of thymic
stromal lymphopoietin by diesel exhaust particles and ambient
particulate matter in human bronchial epithelial cells. J Immunol.
190:3757–3763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Nakahama T, Hanieh H, Nguyen NT, Chinen I,
Ripley B, Millrine D, Lee S, Nyati KK, Dubey PK, Chowdhury K, et
al: Aryl hydrocarbon receptor-mediated induction of the
microRNA-132/212 cluster promotes interleukin-17-producing T-helper
cell differentiation. Proc Natl Acad Sci USA. 110:11964–11969.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Yang W, Wei J, Guo T, Shen Y and Liu F:
Knockdown of miR-210 decreases hypoxic glioma stem cells stemness
and radioresistance. Exp Cell Res. 326:22–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Papi A, Storci G, Guarnieri T, De Carolis
S, Bertoni S, Avenia N, Sanguinetti A, Sidoni A, Santini D,
Ceccarelli C, et al: Peroxisome proliferator activated
receptor-α/hypoxia inducible factor-1α interplay sustains carbonic
anhydrase IX and apoliprotein E expression in breast cancer stem
cells. PLoS One. 8:e549682013. View Article : Google Scholar
|
|
81
|
Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N,
Zhu Z, Mo Z, Wu C and Chen X: MiR-21 regulates
epithelial-mesenchymal transition phenotype and hypoxia-inducible
factor-1α expression in third-sphere forming breast cancer stem
cell-like cells. Cancer Sci. 103:1058–1064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhang KL, Zhou X, Han L, Chen LY, Chen LC,
Shi ZD, Yang M, Ren Y, Yang JX, Frank TS, et al: MicroRNA-566
activates EGFR signaling and its inhibition sensitizes glioblastoma
cells to nimo-tuzumab. Mol Cancer. 13:632014. View Article : Google Scholar
|
|
83
|
Bao B, Ali S, Ahmad A, Azmi AS, Li Y,
Banerjee S, Kong D, Sethi S, Aboukameel A, Padhye SB, et al:
Hypoxia-induced aggressiveness of pancreatic cancer cells is due to
increased expression of VEGF, IL-6 and miR-21, which can be
attenuated by CDF treatment. PLoS One. 7:e501652012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Bao B, Ahmad A, Kong D, Ali S, Azmi AS, Li
Y, Banerjee S, Padhye S and Sarkar FH: Hypoxia induced
aggressiveness of prostate cancer cells is linked with deregulated
expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.
PLoS One. 7:e437262012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Babar IA, Czochor J, Steinmetz A, Weidhaas
JB, Glazer PM and Slack FJ: Inhibition of hypoxia-induced miR-155
radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther.
12:908–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kang SG, Lee WH, Lee YH, Lee YS and Kim
SG: Hypoxia-inducible factor-1α inhibition by a pyrrolopyrazine
metabolite of oltipraz as a consequence of microRNAs 199a-5p and
20a induction. Carcinogenesis. 33:661–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang C, Song B, Song W, Liu J, Sun A, Wu
D, Yu H, Lian J, Chen L and Han J: Underexpressed microRNA-199b-5p
targets hypoxia-inducible factor-1α in hepatocellular carcinoma and
predicts prognosis of hepatocellular carcinoma patients. J
Gastroenterol Hepatol. 26:1630–1637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hu W, Zhao J and Pei G: Activation of aryl
hydrocarbon receptor (ahr) by tranilast, an anti-allergy drug,
promotes miR-302 expression and cell reprogramming. J Biol Chem.
288:22972–22984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Joo MS, Lee CG, Koo JH and Kim SG:
miR-125b transcriptionally increased by Nrf2 inhibits AhR
repressor, which protects kidney from cisplatin-induced injury.
Cell Death Dis. 4:e8992013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Dejean E, Renalier MH, Foisseau M, Agirre
X, Joseph N, de Paiva GR, Al Saati T, Soulier J, Desjobert C,
Lamant L, et al: Hypoxia-microRNA-16 downregulation induces VEGF
expression in anaplastic lymphoma kinase (ALK)-positive anaplastic
large-cell lymphomas. Leukemia. 25:1882–1890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
He M, Wang QY, Yin QQ, Tang J, Lu Y, Zhou
CX, Duan CW, Hong DL, Tanaka T, Chen GQ, et al: HIF-1α
downregulates miR-17/20a directly targeting p21 and STAT3: A role
in myeloid leukemic cell differentiation. Cell Death Differ.
20:408–418. 2013. View Article : Google Scholar :
|
|
92
|
Bertozzi D, Marinello J, Manzo SG, Fornari
F, Gramantieri L and Capranico G: The natural inhibitor of DNA
topoisomerase I, camptothecin, modulates HIF-1α activity by
changing miR expression patterns in human cancer cells. Mol Cancer
Ther. 13:239–248. 2014. View Article : Google Scholar
|
|
93
|
Lichner Z, Mejia-Guerrero S, Ignacak M,
Krizova A, Bao TT, Girgis AH, Youssef YM and Yousef GM: Pleiotropic
action of renal cell carcinoma-dysregulated miRNAs on
hypoxia-related signaling pathways. Am J Pathol. 180:1675–1687.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Kao SY, Tsai MM, Wu CH, Chen JJ, Tseng SH,
Lin SC and Chan KW: Co-targeting of multiple microRNAs on
factor-inhibiting hypoxia-inducible factor (FIH) gene for the
pathogenesis of head and neck carcinomas. Head Neck. Oct
28–2014.(Epub ahead of print). View Article : Google Scholar
|
|
95
|
Mathew LK, Lee SS, Skuli N, Rao S, Keith
B, Nathanson KL, Lal P and Simon MC: Restricted expression of
miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas
enhances HIF2α activity. Cancer Discov. 4:53–60. 2014. View Article : Google Scholar :
|
|
96
|
Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY,
Wu KJ, Chiou SH, Lin SC and Chang KW: miR-31 ablates expression of
the HIF regulatory factor FIH to activate the HIF pathway in head
and neck carcinoma. Cancer Res. 70:1635–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ghosh AK, Shanafelt TD, Cimmino A,
Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia
AJ, et al: Aberrant regulation of pVHL levels by microRNA promotes
the HIF/VEGF axis in CLL B cells. Blood. 113:5568–5574. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Yang Z, Han Y, Cheng K, Zhang G and Wang
X: miR-99a directly targets the mTOR signalling pathway in breast
cancer side population cells. Cell Prolif. 47:587–595. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Blick C, Ramachandran A, Wigfield S,
McCormick R, Jubb A, Buffa FM, Turley H, Knowles MA, Cranston D,
Catto J, et al: Hypoxia regulates FGFR3 expression via HIF-1α and
miR-100 and contributes to cell survival in non-muscle invasive
bladder cancer. Br J Cancer. 109:50–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Tao T, Li G, Dong Q, Liu D, Liu C, Han D,
Huang Y, Chen S, Xu B and Chen M: Loss of SNAIL inhibits cellular
growth and metabolism through the miR-128-mediated RPS6KB1/
HIF-1alpha/PKM2 signaling pathway in prostate cancer cells. Tumour
Biol. 35:8543–8550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Umezu T, Tadokoro H, Azuma K, Yoshizawa S,
Ohyashiki K and Ohyashiki JH: Exosomal miR-135b shed from hypoxic
multiple myeloma cells enhances angiogenesis by targeting
factor-inhibiting HIF-1. Blood. 124:3748–3757. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Song T, Zhang X, Wang C, Wu Y, Cai W, Gao
J and Hong B: MiR-138 suppresses expression of hypoxia-inducible
factor 1α (HIF-1α) in clear cell renal cell carcinoma 786-O cells.
Asian Pac J Cancer Prev. 12:1307–1311. 2011.
|
|
103
|
Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X,
Yu J, Guan X, Jiang BH and Liu LZ: Downregulation of miR-145
associated with cancer progression and VEGF transcriptional
activation by targeting N-RAS and IRS1. Biochim Biophys Acta.
1829:239–247. 2013. View Article : Google Scholar
|
|
104
|
Yu ZY, Bai YN, Luo LX, Wu H and Zeng Y:
Expression of microRNA-150 targeting vascular endothelial growth
factor-A is downregulated under hypoxia during liver regeneration.
Mol Med Rep. 8:287–293. 2013.PubMed/NCBI
|
|
105
|
Sun X, Wei L, Chen Q and Terek RM:
MicroRNA regulates vascular endothelial growth factor expression in
chondrosarcoma cells. Clin Orthop Relat Res. 473:907–913. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Song Z, Ren H, Gao S, Zhao T, Wang X,
Zhang S, Zhao X, Jia L, Sun J and Hao J: The hypoxia-inducible
factor-1 regulates the microRNA185 expression through binding to
hypoxia response elements sequence 2. Med Oncol. 30:7562013.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Raimondi L, Amodio N, Di Martino MT,
Altomare E, Leotta M, Caracciolo D, Gullà A, Neri A, Taverna S,
D’Aquila P, et al: Targeting of multiple myeloma-related
angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor
activity. Oncotarget. 5:3039–3054. 2014.PubMed/NCBI
|
|
108
|
Qu A, Du L, Yang Y, Liu H, Li J, Wang L,
Liu Y, Dong Z, Zhang X, Jiang X, et al: Hypoxia-inducible MiR-210
is an independent prognostic factor and contributes to metastasis
in colorectal cancer. PLoS One. 9:e909522014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Crosby ME, Kulshreshtha R, Ivan M and
Glazer PM: MicroRNA regulation of DNA repair gene expression in
hypoxic stress. Cancer Res. 69:1221–1229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Kim HW, Haider HK, Jiang S and Ashraf M:
Ischemic preconditioning augments survival of stem cells via
miR-210 expression by targeting caspase-8-associated protein 2. J
Biol Chem. 284:33161–33168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn
PO, Sathyan P, Imtiyaz HZ, Zhang Z, Davuluri RV, Rao S, et al:
miR-218 opposes a critical RTK-HIF pathway in mesenchymal
glioblastoma. Proc Natl Acad Sci USA. 111:291–296. 2014. View Article : Google Scholar :
|
|
112
|
Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan
C, Liu S and Zhang Y: MiR-338–3p inhibits hepatocarcinoma cells and
sensitizes these cells to sorafenib by targeting hypoxia-induced
factor 1α. PLoS One. 9:e1155652014. View Article : Google Scholar
|
|
113
|
Sohn EJ, Won G, Lee J, Lee S and Kim SH:
Upregulation of miRNA3195 and miRNA374b mediates the
anti-angiogenic properties of melatonin in hypoxic PC-3 prostate
cancer cells. J Cancer. 6:19–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Seok JK, Lee SH, Kim MJ and Lee YM:
MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the
tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res.
42:8062–8072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Zhang D, Shi Z, Li M and Mi J:
Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy
by inhibiting apoptosis. Cell Death Dis. 5:e13012014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Oda Y, Nakajima M, Mohri T, Takamiya M,
Aoki Y, Fukami T and Yokoi T: Aryl hydrocarbon receptor nuclear
translocator in human liver is regulated by miR-24. Toxicol Appl
Pharmacol. 260:222–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Huang TC, Chang HY, Chen CY, Wu PY, Lee H,
Liao YF, Hsu WM, Huang HC and Juan HF: Silencing of miR-124 induces
neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and
apoptosis through promoting AHR. FEBS Lett. 585:3582–3586. 2011.
View Article : Google Scholar : PubMed/NCBI
|
